Vigonvita Life Sciences Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	217.26	102.1	11.83	199.65
Revenue Growth	-	762.88%	-94.07%	-
Cost of Revenue	30.45	21.42	8.35	6.01
Gross Profit	186.81	80.68	3.49	193.64
Selling, General & Admin	264.54	209.27	69.39	52.51
Research & Development	185.53	202.5	134.86	131.3
Operating Expenses	452.19	414.96	207.15	186.39
Operating Income	-265.37	-334.28	-203.66	7.25
Interest Expense	-14.44	-13.36	-16.16	-7.2
Interest & Investment Income	2.98	0.66	0.71	1.79
Currency Exchange Gain (Loss)	-10.91	-2.85	0.24	0.25
Other Non Operating Income (Expenses)	-13.53	-6.38	1.21	4.34
EBT Excluding Unusual Items	-301.27	-356.2	-217.67	6.43
Gain (Loss) on Sale of Investments	-4.28	-0.71	0.22	-
Gain (Loss) on Sale of Assets	-	-	-0.04	-
Other Unusual Items	-	-	-0.16	-
Pretax Income	-305.55	-356.9	-217.64	6.43
Income Tax Expense	-	0.21	-	-
Earnings From Continuing Operations	-305.55	-357.11	-217.64	6.43
Minority Interest in Earnings	0.78	1.39	6.24	5.66
Net Income	-304.78	-355.72	-211.4	12.09
Net Income to Common	-304.78	-355.72	-211.4	12.09
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	161	153	146	145
Shares Outstanding (Diluted)	161	153	146	145
Shares Change	7.22%	4.87%	0.69%	-
EPS (Basic)	-1.89	-2.33	-1.45	0.08
EPS (Diluted)	-1.89	-2.33	-1.45	0.08
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-	-256.64	-186.53	-56.05
Free Cash Flow Per Share	-	-1.68	-1.28	-0.39
Gross Margin	85.98%	79.02%	29.47%	96.99%
Operating Margin	-122.14%	-327.41%	-1721.30%	3.63%
Profit Margin	-140.28%	-348.42%	-1786.71%	6.05%
Free Cash Flow Margin	-	-251.38%	-1576.46%	-28.07%
EBITDA	-239.58	-310.27	-183.23	14.12
EBITDA Margin	-110.27%	-	-	7.07%
D&A For EBITDA	25.79	24.01	20.44	6.87
EBIT	-265.37	-334.28	-203.66	7.25
EBIT Margin	-122.14%	-	-	3.63%